Toggle navigation
Home
Cinfa Products
Atorcor
Ziquin
Olmedine
Presentations
Contact us
Home Page
Forum
Sign in
Cinfalair 1-12-2018
Cinfalair 1-12-2018
What is Cinfalair’s mechanism of action?
Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT 1 receptor )
Montelukast sodium is a non-selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT 1 receptor )
Montelukast sodium is a selective and orally active leukotriene receptor agonist
none of the above
Cinfalair is indicated in
Management and prophylaxis of asthma.
EIA Exercise Induced Asthma.
Allergic rhinitis.
All the above
None of the above
Cinfalair’s recommend dose for 2 to 5 years is:
One 4 mg sachet mixed with food in the evening
One 4mg tablet in the evening
One 5 mg tablet in the evening
One 10mg tablet in the evening
Cinfalair Defined Market include:
LTR Antagonist.
LABA+ICS
ICS
All the above
Non of the above
